Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China

Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China

Primaquine, the only licensed antimalarial drug for eradication of Plasmodium vivax and Plasmodium ovale malaria, may cause acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd) during treatment. The different prevalence and distribution patterns of G6PDd in...

Full description

Bibliographic Details
Main Authors: Wen Zeng, Ning Liu, Yuchun Li, Ai Gao, Mengyi Yuan, Rui Ma, Na Jiang, Dingwei Sun, Guangze Wang, Xinyu Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Public Health
Subjects:
G6PD
primaquine
vivax malaria
spatial cluster
prevalence
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1010172/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.1010172/full

Similar Items